Taking a look at what insiders are doing to gauge the Jaguar Health Inc. (JAGX)’s direction

As published in their initiating research note from Cantor Fitzgerald on July 07, 2021, Jaguar Health Inc. [JAGX] has been an Overweight and the price target has been revised to $5. This represents a 96.4% premium over Wednesday’s closing price. Analysts at Rodman & Renshaw started covering the stock with ‘”a Buy”‘ outlook in a report released in mid July.


Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now. .

Sponsored


Analyzing JAGX’s Price Performance

On Wednesday, Jaguar Health Inc. [NASDAQ: JAGX] plunged -1.69% to $0.18. The stock’s lowest price that day was $0.1802, but it reached a high of $0.19 in the same session. During the last five days, there has been a drop of approximately -21.70%. Over the course of the year, Jaguar Health Inc. shares have dropped approximately -82.65%. Shares of the company reached a 52-week high of $1.1300 on 01/04/22 and a 52-week low of $0.1801 on 09/19/22. A 50-day SMA is recorded $0.2594, while a 200-day SMA reached $0.5259. Nevertheless, trading volume fell to 1.8 million shares from 2.45 million shares the previous day.

Support And Resistance Levels for Jaguar Health Inc. (JAGX)

According to the 24-hour chart, there is a support level at 0.1771, which, if violated, would cause prices to drop to 0.1737. In the upper region, resistance lies at 0.1869. The next price resistance is at 0.1933. RSI (Relative Strength Index) is 27.37 on the 14-day chart, showing oversold technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.0294, which suggests the price will decrease in the coming days. Percent R is at 99.61%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.

Is Jaguar Health Inc. subject to short interest?

Stocks of Jaguar Health Inc. saw a sharp rise in short interest on Jul 14, 2022 jumping by 0.27 million shares to 4.78 million. Data from Yahoo Finance shows that the short interest on Jun 14, 2022 was 4.51 million shares. A jump of 5.65% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 2 of the overall float, the days-to-cover ratio (short ratio) jumped to 2.

Which companies own the most shares of Jaguar Health Inc. (JAGX)?

According to The Vanguard Group, Inc. filings, the company currently owns 2,196,921 shares, which is about 2.78% of the total JAGX shares outstanding. The investor’s shares have appreciated by 1,136,708 from its previous 13-F filing of 1060213.0 shares. With the completion of the sale transaction, Renaissance Technologies LLC’s stake is now worth $278,885. BlackRock Fund Advisors reduced a -13.88% interest valued at $0.15 million while Millennium Management LLC purchased a 321,795 stake. A total of 30,507 shares of Jaguar Health Inc. were bought by Geode Capital Management LLC during the quarter, and -961 were sold by The Bank of New York Mellon Corp. In its current portfolio, Virtu Financial BD LLC holds 154,275 shares valued at $36255.0.

In terms of Jaguar Health Inc. share price expectations, FactSet research, analysts set an average price target of $5.00 in the next 12 months, up nearly 2677.78% from the previous closing price of $0.18. Analysts anticipate Jaguar Health Inc. stock to reach $5.00 by 2022, with the lowest price target being $5.00. In spite of this, 1 analysts ranked Jaguar Health Inc. stock as a Buy at the end of 2022.

LEAVE A REPLY

Please enter your comment!
Please enter your name here